ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN)

Filing manager: ARMISTICE CAPITAL, LLC
Reporting owner: Armistice Capital, LLC
Security: SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol: SUPN
Shares outstanding: 57,344,398 shares
Disclosed shares: 2,764,000 shares
Disclosed ownership percentage: 4.8%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 21:37:59 UTC
Event date: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC filing: View on sec.gov

Key filing fact

ARMISTICE CAPITAL, LLC disclosed 4.8% ownership in SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN) on 31 Dec 2025.

Key facts

ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN).
Disclosed ownership: 4.8%.
Date of event: 31 Dec 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	4.8%	2,764,000	0	2,764,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	4.8%	2,764,000	0	2,764,000	/s/ Steven Boyd	Steven Boyd

CIK / CUSIP context first

Broader feeds